Fluticasone Umeclidin Vilanter
A three-drug inhaler (fluticasone, umeclidinium, and vilanterol) used once daily for the maintenance treatment of COPD and asthma.
United States
$316
per month
India
$30
per month
You save
−90%save $285/mo · 90% cheaper
6.3M US scripts/yr$1.8B potential annual savings$2B US spend/yr
Compare the price
US price$316per month
India price$30per month
You save$28590% less
Based on 30 units per month. US $10.52 vs India $1.01 per unit.
Total over 1 periodSave $285$316 → $30
The bigger picture
Fluticasone Umeclidin Vilanter is filled about 6.3M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$2B
If sourced from India
$190.2M
Potential annual savings
$1.8B
−90%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.